Cargando…

Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity

Current therapy against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are based on the use of Remdesivir 1, Molnupiravir 2, and the recently identified Nirmatrelvir 3. Unfortunately, these three drugs showed some limitations regarding potency and possible drug–drug interactions....

Descripción completa

Detalles Bibliográficos
Autores principales:	Cesarini, Silvia, Vicenti, Ilaria, Poggialini, Federica, Secchi, Massimiliano, Giammarino, Federica, Varasi, Ilenia, Lodola, Camilla, Zazzi, Maurizio, Dreassi, Elena, Maga, Giovanni, Botta, Lorenzo, Saladino, Raffaele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782877/ https://www.ncbi.nlm.nih.gov/pubmed/36557962 http://dx.doi.org/10.3390/molecules27248829

Ejemplares similares

s-Triazine: A Privileged Structure for Drug Discovery and Bioconjugation
por: Sharma, Anamika, et al.
Publicado: (2021)

Design and Synthesis of New 1,3,5‐Trisubstituted Triazines for the Treatment of Cancer and Inflammation
por: Zacharie, Boulos, et al.
Publicado: (2018)

Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme
por: Poggialini, Federica, et al.
Publicado: (2023)

DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective
por: Secchi, Massimiliano, et al.
Publicado: (2022)

Trisubstituted 1,3,5-Triazines as Histamine H(4) Receptor Antagonists with Promising Activity In Vivo
por: Olejarz-Maciej, Agnieszka, et al.
Publicado: (2023)

Progress towards Adjuvant Development: Focus on Antiviral Therapy
por: Brai, Annalaura, et al.
Publicado: (2023)

Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model
por: Brai, Annalaura, et al.
Publicado: (2023)

sym-Trisubstituted 1,3,5-Triazine Derivatives as Promising Organic Corrosion Inhibitors for Steel in Acidic Solution
por: El-Faham, Ayman, et al.
Publicado: (2016)

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
por: Oyagawa, Caitlin R. M., et al.
Publicado: (2018)

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
Publicado: (2019)

Trisubstituted 1,3,5-Triazines: The First Ligands of the sY12-Binding Pocket on Chemokine CXCL12
por: Sprague, Daniel J., et al.
Publicado: (2021)

Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies
por: Poggialini, Federica, et al.
Publicado: (2023)

Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals
por: Boccuto, Adele, et al.
Publicado: (2021)

Facile Synthesis, Characterization, and In Vitro Antimicrobial Screening of a New Series of 2,4,6-Trisubstituted-s-triazine Based Compounds
por: Singh, Ravi Bhushan, et al.
Publicado: (2015)

Synthesis and PI 3-Kinase Inhibition Activity of Some Novel 2,4,6-Trisubstituted 1,3,5-Triazines
por: Nelson, Ronald A., et al.
Publicado: (2018)

Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro
por: Boccuto, Adele, et al.
Publicado: (2021)

Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles
por: Cichero, Elena, et al.
Publicado: (2017)

Protein-Ligand interaction studies on 2, 4, 6- trisubstituted triazine derivatives as anti-malarial DHFR agents using AutoDock
por: Adinarayana, Katika Prabhakara Surya, et al.
Publicado: (2011)

Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
por: Fiaschi, Lia, et al.
Publicado: (2022)

Interaction of SARS-CoV-2 Nucleocapsid Protein and Human RNA Helicases DDX1 and DDX3X Modulates Their Activities on Double-Stranded RNA
por: Lodola, Camilla, et al.
Publicado: (2023)

SARS-CoV-2 Neutralizing Antibodies to B.1 and to BA.5 Variant after Booster Dose of BNT162b2 Vaccine in HIV Patients COVID-Naïve and on Successful Antiretroviral Therapy
por: Vicenti, Ilaria, et al.
Publicado: (2023)

Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
por: Parisi, Saverio Giuseppe, et al.
Publicado: (2022)

Dendrimeric Structures in the Synthesis of Fine Chemicals
por: Bizzarri, Bruno Mattia, et al.
Publicado: (2021)

Priviléges /
por: Beauvoir, Simone de, 1908-1986
Publicado: (1955)

Privileges
por: Jagannathan, Mukund
Publicado: (2016)

Retraction for Adinarayana & Devi, Protein-Ligand interaction studies on 2, 4, 6-trisubstituted triazine derivatives as anti-malarial DHFR agents using AutoDock
Publicado: (2015)

Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses
por: Grazia Martina, Maria, et al.
Publicado: (2021)

A Relay Strategy Actuates Pre-Existing Trisubstituted Olefins in Monoterpenoids for Cross-Metathesis with Trisubstituted Alkenes
por: Bahou, Karim A., et al.
Publicado: (2020)

The privileged immunity of immune privileged organs: the case of the eye
por: Benhar, Inbal, et al.
Publicado: (2012)

Trisubstituted Pyrazolopyrimidines as Novel Angiogenesis Inhibitors
por: Weitensteiner, Sabine B., et al.
Publicado: (2013)

The Privilege of Suffering
Publicado: (1886)

The Privilege of Suffering
Publicado: (1886)

Ransomware and Privileges
por: Haber, Morey J.
Publicado: (2020)

Privileged Communications
Publicado: (1852)

Atom-efficient synthesis of 2,4,6-trisubstituted 1,3,5-triazines via Fe-catalyzed cyclization of aldehydes with NH(4)I as the sole nitrogen source
por: Xiao, Jiang, et al.
Publicado: (2020)

Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials
por: Norcross, Neil R., et al.
Publicado: (2016)

Iridium-catalyzed enantioconvergent hydrogenation of trisubstituted olefins
por: Peters, Bram B. C., et al.
Publicado: (2022)

Recent Advances in the Synthesis of Di- and Trisubstituted Hydroxylamines
por: Hill, Jarvis, et al.
Publicado: (2023)

HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus, an Endemic Plant of Sardinia (Italy) and Corsica (France)
por: Sanna, Cinzia, et al.
Publicado: (2023)

Ocular immune privilege
por: Zhou, Ru, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_nibq8kks2mfbbp79oag4mbtn1f